Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on developing ivonescimab, an investigational immunotherapy designed to treat life-threatening cancers including non-small cell lung cancer and colorectal cancer. The company is currently conducting multiple global Phase 3 clinical studies (HARMONi, HARMONi-3, HARMONi-7, and HARMONi-GI3) to evaluate ivonescimab in various combinations and indications. Summit's mission centers on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs in oncology. The company is built on core values of integrity, passion for excellence, purposeful urgency, collaboration, and commitment to people, with a team dedicated to touching and changing patients' lives.
Beta · Sourced from candidate reports
Be the first to share your experience with Summit Therapeutics.
Your reply helps other candidates know what to expect.
